Devonian Health Group Inc. announced changes to the Company's Management and Board, effective immediately, include: Luc Grégoire, a current Director of the Company, has been appointed as President of the Company. He will replace Pierre Montanaro who will transition to President of Altius Healthcare Inc., Devonian's commercial subsidiary, to focus on driving further revenue growth. David Baker, a current Director of the Company, has been appointed as non-executive Chairman of the Board.

He will replace Dr. André Boulet who will more fully dedicate his efforts to his continuing role as Chief Scientific Officer, leading the Company's development strategy for its extensive research pipeline. Additionally, Ashish Chabria has resigned from the Company's Board for personal reasons. There are no disputes or disagreements between the Company and him.